Exane Derivatives’s JPMorgan Chase JPM Stock Holding History

Exane Derivatives’s Portfolio JPM Stock Details JPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.43M	Sell	12,673 -1,706	-12%	-$211K	0.82%	26
2022 Q1	$1.96M	Sell	14,379 -6,739	-32%	-$995K	0.55%	36
2021 Q4	$3.34M	Buy	21,118 +2,517	+14%	+$413K	0.81%	17
2021 Q3	$3.04M	Buy	18,601 +1,516	+9%	+$238K	0.73%	23
2021 Q2	$2.66M	Buy	17,085 +190	+1%	+$29.8K	0.6%	26
2021 Q1	$2.57M	Buy	16,895 +1,537	+10%	+$221K	0.74%	29
2020 Q4	$1.95M	Sell	15,358 -2,525	-14%	-$282K	0.57%	33
2020 Q3	$1.72M	Sell	17,883 -3,197	-15%	-$314K	0.5%	40
2020 Q2	$1.98M	Sell	21,080 -8,293	-28%	-$787K	0.53%	53
2020 Q1	$2.64M	Buy	29,373 +3,249	+12%	+$395K	0.74%	34
2019 Q4	$3.57M	Buy	26,124 +13,869	+113%	+$1.78M	0.66%	43
2019 Q3	$1.44M	Buy	12,255 +572	+5%	+$64.7K	0.26%	85
2019 Q2	$1.31M	Buy	11,683 +3,799	+48%	+$419K	0.23%	92
2019 Q1	$798K	Buy	7,884 +6,535	+484%	+$673K	0.16%	129
2018 Q4	$132K	Sell	1,349 -1,000	-43%	-$107K	0.02%	294
2018 Q3	$267K	Sell	2,349 -2,949	-56%	-$335K	0.05%	224
2018 Q2	$564K	Buy	5,298 +143	+3%	+$15.7K	0.09%	170
2018 Q1	$555K	Buy	5,155 +5,095	+8,492%	+$577K	0.11%	158
2017 Q4	$6.43K	Sell	60 -137	-70%	-$13.9K	﹤0.01%	418
2017 Q3	$18.8K	Buy	197 +19	+11%	+$1.75K	﹤0.01%	361
2017 Q2	$16.3K	Sell	178 -1,543	-90%	-$133K	﹤0.01%	371
2017 Q1	$151K	Sell	1,721 -4,815	-74%	-$425K	0.03%	206
2016 Q4	$564K	Buy	+6,536	New	+$498K	0.11%	146
2016 Q3	–	Sell	-48,825	Closed	-$3.03M	–	644
2016 Q2	$3.03M	Sell	48,825 -21,921	-31%	-$1.37M	0.5%	45
2016 Q1	$4.19M	Buy	70,746 +58,409	+473%	+$3.41M	0.56%	43
2015 Q4	$815K	Sell	12,337 -16,947	-58%	-$1.1M	0.11%	90
2015 Q3	$1.79M	Buy	29,284 +22,440	+328%	+$1.47M	0.23%	69
2015 Q2	$464K	Buy	6,844 +4,613	+207%	+$301K	0.05%	146
2015 Q1	$135K	Sell	2,231 -7,069	-76%	-$419K	0.01%	247
2014 Q4	$582K	Buy	+9,300	New	+$560K	0.08%	130

Other funds holding JPM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Derivatives's JPM Position: Q2 2022 in Review

Exane Derivatives reduced its JPMorgan Chase (JPM) stake by 12% in Q2 2022, selling an estimated $211K and leaving 12,673 shares worth $1.43M. The position accounts for 0.82% of the portfolio, ranked #26.

Exane Derivatives first reported a position in JPM in Q4 2014 and has held it in 30 quarters since. The position peaked at $4.19M in Q1 2016. 3,422 funds tracked by Wall St. Rank hold JPM as of Q2 2022.

Exane Derivatives held 12,673 shares of JPMorgan Chase worth $1.43M as of Q2 2022.
Exane Derivatives sold 1,706 JPMorgan Chase shares in Q2 2022, an estimated $211K.
JPMorgan Chase made up 0.82% of Exane Derivatives's portfolio in Q2 2022, its #26 holding.
Exane Derivatives first reported a position in JPMorgan Chase in Q4 2014 and has held it in 30 quarters since.
Exane Derivatives's JPMorgan Chase position peaked at $4.19M in Q1 2016.
3,422 funds tracked by Wall St. Rank held JPMorgan Chase as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.